| scholarly article | Q13442814 |
| P2093 | author name string | H Sato | |
| M Seiki | |||
| Y Okada | |||
| T Aoki | |||
| E Ohuchi | |||
| T Harayama | |||
| P2860 | cites work | Expression of membrane-type matrix metalloproteinase in human gastric carcinomas | Q71887264 |
| Calcium ionophores decrease pericellular gelatinolytic activity via inhibition of 92-kDa gelatinase expression and decrease of 72-kDa gelatinase activation | Q71892140 | ||
| Expression and tissue localization of membrane-types 1, 2, and 3 matrix metalloproteinases in human invasive breast carcinomas | Q73352931 | ||
| Enhanced production and activation of progelatinase A mediated by membrane-type 1 matrix metalloproteinase in human papillary thyroid carcinomas | Q77931928 | ||
| A matrix metalloproteinase expressed on the surface of invasive tumour cells | Q24312733 | ||
| Cloning of a disintegrin metalloproteinase that processes precursor tumour-necrosis factor-alpha | Q24319999 | ||
| A metalloproteinase disintegrin that releases tumour-necrosis factor-alpha from cells | Q28119154 | ||
| Tumor cell interactions with the extracellular matrix during invasion and metastasis | Q28258256 | ||
| Intermolecular autolytic cleavage can contribute to the activation of progelatinase A by cell membranes | Q28618959 | ||
| TIMP-2 promotes activation of progelatinase A by membrane-type 1 matrix metalloproteinase immobilized on agarose beads | Q28619217 | ||
| A metalloprotease inhibitor blocks shedding of the IL-6 receptor and the p60 TNF receptor | Q34298512 | ||
| Complex regulation of membrane-type matrix metalloproteinase expression and matrix metalloproteinase-2 activation by concanavalin A in MDA-MB-231 human breast cancer cells | Q34300183 | ||
| Membrane-type matrix metalloproteinase (MT-MMP) gene is expressed in stromal cells of human colon, breast, and head and neck carcinomas | Q34497741 | ||
| Increased amyloidogenic secretion in cerebellar granule cells undergoing apoptosis | Q35802215 | ||
| Activity of type IV collagenases in benign and malignant breast disease | Q35976755 | ||
| Loss and shedding of surface markers from the leukemic myeloid monocytic line THP-1 induced to undergo apoptosis | Q36802000 | ||
| Isolation of a mouse MT2-MMP gene from a lung cDNA library and identification of its product | Q36847047 | ||
| Cleavage of the membrane precursor for transforming growth factor alpha is a regulated process | Q37414612 | ||
| Membrane proteins with soluble counterparts: role of proteolysis in the release of transmembrane proteins | Q37423113 | ||
| Soluble receptors for cytokines and growth factors: generation and biological function | Q40656511 | ||
| Programmed cell death, apoptosis and killer genes | Q40813094 | ||
| Membrane type 1 matrix metalloproteinase digests interstitial collagens and other extracellular matrix macromolecules | Q41133261 | ||
| Regulation of membrane-type matrix metalloproteinase-1 expression by growth factors and phorbol 12-myristate 13-acetate. | Q41184688 | ||
| Membrane-type matrix metalloproteinase 1 is a gelatinolytic enzyme and is secreted in a complex with tissue inhibitor of metalloproteinases 2. | Q41191397 | ||
| Diverse cell surface protein ectodomains are shed by a system sensitive to metalloprotease inhibitors. | Q41199229 | ||
| A one-step sandwich enzyme immunoassay for human matrix metalloproteinase 7 (matrilysin) using monoclonal antibodies | Q41236859 | ||
| Cleavage processing of angiotensin-converting enzyme by a membrane-associated metalloprotease | Q41284613 | ||
| Membrane protein secretases | Q41341215 | ||
| Cell growth-promoting activity of tissue inhibitor of metalloproteinases-2 (TIMP-2). | Q41445433 | ||
| Regulation of tumour necrosis factor-alpha processing by a metalloproteinase inhibitor | Q41447978 | ||
| Protection against a lethal dose of endotoxin by an inhibitor of tumour necrosis factor processing | Q41454044 | ||
| Activation mechanisms of matrix metalloproteinases. | Q41482018 | ||
| Non-amyloidogenic cleavage of the beta-amyloid precursor protein by an integral membrane metalloendopeptidase | Q41493231 | ||
| Expression of membrane-type 1 matrix metalloproteinase and activation of progelatinase A in human osteoarthritic cartilage. | Q42049394 | ||
| Concanavalin A induced apoptosis in fibroblasts: the role of cell surface carbohydrates in lectin mediated cytotoxicity | Q42824058 | ||
| Glucocorticoids activate a suicide process in thymocytes through an elevation of cytosolic Ca2+ concentration | Q43535256 | ||
| Regulation of programmed death in erythroid progenitor cells by erythropoietin: Effects of calcium and of protein and RNA syntheses | Q43702503 | ||
| Processing of tumour necrosis factor-α precursor by metalloproteinases | Q59059630 | ||
| Tumor necrosis factor alpha induces apoptosis in mammary adenocarcinoma cells by an increase in intranuclear free Ca2+ concentration and DNA fragmentation | Q67748964 | ||
| Mitogen stimulation of T-cells increases c-Fos and c-Jun protein levels, AP-1 binding and AP-1 transcriptional activity | Q68025996 | ||
| Activation of the precursor of gelatinase A/72 kDa type IV collagenase/MMP-2 in lung carcinomas correlates with the expression of membrane-type matrix metalloproteinase (MT-MMP) and with lymph node metastasis | Q71820200 | ||
| Plasma membrane-dependent activation of gelatinase A in human vascular endothelial cells | Q71825059 | ||
| P433 | issue | 9 | |
| P921 | main subject | breast carcinoma | Q18555947 |
| P1104 | number of pages | 9 | |
| P304 | page(s) | 942-950 | |
| P577 | publication date | 1999-09-01 | |
| P1433 | published in | Japanese Journal of Cancer Research | Q26842384 |
| P1476 | title | Shedding of membrane type 1 matrix metalloproteinase in a human breast carcinoma cell line | |
| P478 | volume | 90 |
| Q28360869 | Calmodulin inhibitors trigger the proteolytic processing of membrane type-1 matrix metalloproteinase, but not its shedding in glioblastoma cells |
| Q40488762 | Cleavage at the stem region releases an active ectodomain of the membrane type 1 matrix metalloproteinase |
| Q40732890 | Complex pattern of membrane type 1 matrix metalloproteinase shedding. Regulation by autocatalytic cells surface inactivation of active enzyme |
| Q24338121 | Detection of a latent soluble form of membrane type 1 matrix metalloprotease bound with tissue inhibitor of matrix metalloproteinases-2 in periprosthetic tissues and fluids from loose arthroplasty endoprostheses |
| Q40531063 | Induction of membrane-type-1 matrix metalloproteinase by epidermal growth factor-mediated signaling in gliomas. |
| Q35107597 | Membrane type-matrix metalloproteinases (MT-MMP) |
| Q46497091 | Mutational and structural analyses of the hinge region of membrane type 1-matrix metalloproteinase and enzyme processing |
| Q35770288 | Processing, shedding, and endocytosis of membrane type 1-matrix metalloproteinase (MT1-MMP). |
| Q50629332 | Purification of matrix metalloproteinases by column chromatography. |
| Q55267464 | Significance of matrix metalloproteinases in the pathophysiology of the ovary and uterus. |
| Q34444294 | The role of matrix metalloproteinase genes in glioma invasion: co-dependent and interactive proteolysis |
Search more.